High Cholesterol: The LDL Targets, Statin Intensity, Muscle Aches and the Test Done Once in a Lifetime
Cholesterol causes nothing you can feel, which is why the only thing that matters about it is a number and how long that number stays where it is. The damage is cumulative exposure: LDL multiplied by years.
And the benefit of lowering it is measurable rather than theoretical. Across the large trials, each 1 mmol/L reduction in LDL cholesterol — about 39 mg/dL — reduces major vascular events by roughly a fifth per year of treatment, and the effect accumulates the longer treatment continues. That figure is the whole case for taking this seriously.
📊 The panel, and the target that depends on who you are
The same LDL carries very different risk in different people, which is why there is no single correct value.
| Marker | General reference | What it means |
|---|---|---|
| LDL cholesterol | Target depends on risk — see below | The plaque driver. The one number treatment is aimed at |
| Total cholesterol | Below 200 mg/dL, 5.2 mmol/L | Crude. Less useful than LDL and now rarely used alone |
| HDL cholesterol | Above 40 mg/dL in men, 50 in women | Associated with lower risk, and raising it with drugs has never reduced events. A high HDL does not cancel a high LDL |
| Triglycerides | Below 150 mg/dL, 1.7 mmol/L | Mostly a metabolic signal. Becomes an urgent target of its own above 500 — see below |
| Non-HDL cholesterol | LDL target plus 30 mg/dL | Captures all the harmful particles. Useful when triglycerides are high and LDL is misleading |
🎯 The LDL targets
| Risk category | Who | LDL target |
|---|---|---|
| Moderate | No diabetes, no established disease, limited risk factors | Below 100 mg/dL (2.6 mmol/L) |
| High | Diabetes, chronic kidney disease, markedly raised single risk factor, or a high calculated risk score | Below 70 mg/dL (1.8 mmol/L), and at least a 50 percent reduction from baseline |
| Very high | Established disease — previous heart attack, stroke, stent, bypass, peripheral arterial disease — or diabetes with organ damage | Below 55 mg/dL (1.4 mmol/L), and at least a 50 percent reduction |
Note the second half of those last two rows. Reaching the number is not enough if the percentage reduction is small, and vice versa. Both conditions are meant to be met.
💡 Two practical things about the blood test itself.
You usually do not need to fast. Non-fasting lipid panels are now accepted for routine assessment in most guidelines, which removes a genuine barrier to getting tested. Fasting is still asked for when triglycerides are very high or when a specific calculation is needed.
One high reading is not a diagnosis. LDL varies between tests, and a single elevated value during an acute illness or after a heavy period of eating is not a basis for lifelong treatment. Two measurements, a few weeks apart.
🧬 The test to have once in your life
Lipoprotein(a), written Lp(a), is a particle that carries cholesterol and is determined almost entirely by genetics. It is elevated in roughly one person in five, it is an independent driver of heart attack and stroke, and it does not change meaningfully with diet, exercise or statins.
Because it is genetic and stable, it is measured once and the answer lasts for life. Knowing it changes decisions: someone with a raised Lp(a) and an otherwise unremarkable panel sits in a higher risk category than their other numbers suggest, which justifies lowering LDL further and harder. And because it runs in families, a high result is a reason to test relatives.
It is not on a standard lipid panel and has to be asked for. It is particularly worth requesting with a family history of early cardiovascular events, with established disease at a young age, or where the conventional risk factors do not explain what has happened.
👪 The condition that runs in families and is routinely missed
⚠️ Familial hypercholesterolaemia affects roughly one person in 250 — far commoner than most people assume — and causes very high LDL from birth, with heart attacks in the forties and fifties if untreated. The large majority of people who have it do not know.
Suspect it when: LDL is above 190 mg/dL (4.9 mmol/L) in an adult, or above 160 with a family history; a parent or sibling had a heart attack or stroke before 55 in men or 65 in women; or there are tendon xanthomas — firm lumps over the Achilles or the knuckles — or a pale ring around the cornea before the age of 45.
The reason it matters beyond the individual: each first-degree relative has a one in two chance of having it too, and cascade testing of the family finds people decades before anything happens to them. A diagnosis in one person is a diagnosis waiting to be made in several.
💊 Statin intensity, which is the thing to actually ask about
The useful question is not whether you are on a statin. It is how much LDL reduction your particular statin at your particular dose produces, because that varies from under 30 percent to over 50 percent.
| Intensity | LDL reduction | Which drug and dose | Used for |
|---|---|---|---|
| High | 50 percent or more | Atorvastatin 40 to 80 mg, or rosuvastatin 20 to 40 mg | Established cardiovascular disease, very high risk, familial hypercholesterolaemia |
| Moderate | 30 to 49 percent | Atorvastatin 10 to 20 mg, rosuvastatin 5 to 10 mg, simvastatin 20 to 40 mg, pravastatin 40 to 80 mg | Most primary prevention |
| Low | Under 30 percent | Simvastatin 10 mg, pravastatin 10 to 20 mg, lovastatin 20 mg | Where higher doses are not tolerated |
Two points that follow from this table.
Anyone with established disease should be on high-intensity therapy unless there is a reason they cannot be, and that means atorvastatin or rosuvastatin rather than a moderate-intensity statin at any dose. If you have had a heart attack and are on simvastatin 20 mg, that is a conversation worth having.
Simvastatin 80 mg is not used. It was withdrawn from routine use because the myopathy risk at that dose outweighed the extra benefit. The practical ceiling for simvastatin is 40 mg, which is why it cannot deliver high-intensity therapy.
Take it at a consistent time. Simvastatin and lovastatin work better taken in the evening because cholesterol synthesis peaks overnight; atorvastatin and rosuvastatin last long enough that timing does not matter. The full range is in the cholesterol category.
💪 Muscle aches: the honest version
This is the reason more people stop statins than any other, and the evidence here is genuinely surprising.
🔎 What the blinded studies found. Muscle symptoms are reported by a substantial minority of people taking statins in ordinary practice. But in trials where people who had previously stopped statins because of muscle pain were given the statin and a placebo in alternating blinded periods, most reported much the same symptoms in both, and the large majority were able to restart treatment afterwards.
That does not mean the pain is imagined — the symptoms were real and recorded. It means the statin frequently was not what was causing them, and that the common conclusion of statins and I do not get on, never again is usually wrong.
True statin myopathy, with muscle enzyme levels many times normal, is rare. Rhabdomyolysis is rarer still.
So the approach is a sequence rather than permanent abandonment:
- ⏸️ Stop for two to four weeks and see whether the symptoms actually resolve. If they do not, the statin was not the cause and it can be restarted
- 🧪 Check creatine kinase if the pain is severe or widespread, and check thyroid function and vitamin D, both of which cause muscle pain and are often the real answer
- 🔄 Rechallenge — the same statin at a lower dose, or a different one. Hydrophilic statins such as pravastatin and rosuvastatin enter muscle less readily and are often tolerated when others are not
- 📅 Alternate-day or twice-weekly dosing of a long-acting statin still lowers LDL usefully and is tolerated by many who cannot manage daily
- ➕ A lower statin dose plus ezetimibe achieves a similar reduction to a higher statin dose alone
- 🚫 Only after all of that is someone genuinely statin-intolerant, which is a far smaller group than the number who believe they are
Stop and seek assessment urgently for severe muscle pain with weakness and dark or cola-coloured urine — that is rhabdomyolysis and it damages the kidneys.
🧪 Two monitoring myths
- 🧫 Liver tests do not need repeating routinely. A baseline measurement before starting, and then only if symptoms suggest a problem. The old practice of periodic liver function tests for everyone on a statin has been dropped, because it found almost nothing and frightened people off treatment
- 📈 Creatine kinase is not checked routinely either, only when there are muscle symptoms. A mildly raised level without symptoms is not a reason to stop
What is worth repeating: a lipid panel 8 to 12 weeks after starting or changing treatment, to confirm the target has been reached, then annually once stable. Not checking is how people spend years on a dose that was never enough.
And one honest point: statins slightly increase the number of people diagnosed with type 2 diabetes, mostly in those already close to the threshold. The reduction in heart attacks and strokes substantially outweighs it, and the right response is to monitor glucose rather than to avoid the statin.
➕ When a statin is not enough
Many people do not reach target on a statin alone, particularly the lower targets for established disease. The additions are sequential.
- 🔹 Ezetimibe 10 mg daily — blocks cholesterol absorption in the gut and adds roughly a further 15 to 20 percent LDL reduction on top of a statin. Very well tolerated, few interactions, and the first thing added
- 🔹 Bempedoic acid — an option for those who genuinely cannot take statins, with the caveat that it raises uric acid and can provoke gout
- 🔹 PCSK9 inhibitors — injections every two to four weeks, producing a further 50 to 60 percent reduction. Reserved for very high risk and familial hypercholesterolaemia on cost grounds
- 🔹 Inclisiran — an injection twice a year after loading, acting on the same pathway
Bile acid sequestrants such as cholestyramine remain an option, chiefly where other drugs cannot be used, and are limited by having to be taken as a powder and by interfering with the absorption of other medicines.
🔥 Triglycerides, and the threshold that changes the goal
Moderately raised triglycerides are a signal of insulin resistance and are mostly addressed by treating the metabolic picture — weight, alcohol, refined carbohydrate, and glucose control, covered in our guide to type 2 diabetes.
Above a certain level the reason for treating changes entirely.
- 🟡 150 to 499 mg/dL (1.7 to 5.6 mmol/L) — a cardiovascular risk marker. Lifestyle and the underlying cause; statin first, because LDL remains the priority
- 🔴 500 mg/dL (5.6 mmol/L) and above — now a pancreatitis risk and treated for that reason. Alcohol stopped completely, fat intake reduced sharply, and a fibrate or high-dose omega-3 added
- ⚠️ Above 1000 mg/dL — high risk of acute pancreatitis, which is a medical emergency when it happens. This needs urgent specialist management
One specific drug point: where a fibrate is combined with a statin, fenofibrate is used and gemfibrozil is not, because gemfibrozil with a statin carries a substantially higher risk of muscle breakdown.
⚠️ Interactions that matter
Simvastatin and atorvastatin are broken down by a liver enzyme that many common drugs block, and when they accumulate the muscle risk rises sharply.
- 🦠 Clarithromycin and erythromycin — the statin is usually paused for the duration of the antibiotic course. This is a routine and easily missed situation
- 🍄 Itraconazole, ketoconazole and related antifungals
- 💊 Ciclosporin, some HIV medicines, amiodarone, verapamil and diltiazem — all require a dose cap or a different statin
- 🍊 Grapefruit juice with simvastatin and atorvastatin, where large quantities matter. Pravastatin and rosuvastatin are not affected
- 💧 Gemfibrozil, as above
- 🍷 Heavy alcohol, which compounds both liver and muscle concerns
Pravastatin and rosuvastatin avoid most of this pathway, which makes them the practical choice for anyone on a complicated medication list.
🤰 Pregnancy
Statins are generally stopped before a planned pregnancy and during pregnancy and breastfeeding. Women of childbearing age taking one should know this in advance and have contraception discussed, and anyone planning to conceive should raise it rather than discovering the issue later. The exception is severe familial hypercholesterolaemia, where the decision is made with a specialist.
🥦 Lifestyle, with the percentages attached
These are usually listed without figures, which makes them easy to dismiss. Together they can produce a reduction comparable to a low-dose statin, and they work alongside medication rather than instead of it.
| Change | Typical LDL effect |
|---|---|
| Replacing saturated fat with unsaturated — less butter, fatty meat, pastry, coconut and palm oil; more olive oil, nuts, oily fish | 5 to 10 percent. The single largest dietary lever, and it is about replacement rather than just removal |
| Soluble fibre, 5 to 10 g a day — oats, barley, beans, lentils, apples, psyllium | About 5 percent |
| Plant sterols, around 2 g a day — fortified spreads and drinks | 8 to 10 percent |
| Weight loss | Modest for LDL; substantial for triglycerides |
| Exercise | Little direct effect on LDL; lowers triglycerides and improves everything else that matters |
| Stopping smoking | No effect on LDL and one of the largest effects on actual risk |
Dietary cholesterol itself — eggs, prawns — has much less effect on blood cholesterol than saturated fat does, which is where the old advice was pointed in the wrong direction.
Finally: cholesterol is one of several factors, and treating it in isolation misses the point. Blood pressure, glucose and smoking all multiply the same risk, and our guide to blood pressure covers the second of those.
📞 When to seek help
Urgent:
- Severe muscle pain with weakness and dark urine — stop the statin and seek assessment
- Yellow skin or eyes, dark urine, or right-sided abdominal pain
- Severe upper abdominal pain radiating to the back with vomiting, where triglycerides are known to be very high — possible pancreatitis
Worth an appointment:
- LDL above 190 mg/dL (4.9 mmol/L) — ask specifically about familial hypercholesterolaemia and about testing relatives
- A parent or sibling with a heart attack or stroke before 55 or 65 — ask for a full lipid panel and for Lp(a)
- Established heart disease on a moderate-intensity statin — ask whether high intensity is appropriate
- Never having had a lipid panel rechecked after starting treatment
- Muscle aches — ask for the structured approach above rather than stopping for good
- Triglycerides above 500 mg/dL
- Starting clarithromycin or an antifungal while on simvastatin or atorvastatin
- Planning a pregnancy while on a statin
- Lumps over the Achilles tendons or knuckles, or a pale ring around the cornea under 45
❓ Frequently asked questions
What should my LDL be?
Below 100 mg/dL at moderate risk, below 70 at high risk, and below 55 with established cardiovascular disease — in the last two cases together with at least a 50 percent reduction from baseline. Both conditions are meant to be met.
What is a high-intensity statin?
One that lowers LDL by 50 percent or more, which means atorvastatin 40 to 80 mg or rosuvastatin 20 to 40 mg. Simvastatin and pravastatin are moderate intensity at any usable dose, and simvastatin 80 mg is no longer used.
Do I need to fast before a cholesterol test?
Usually not. Non-fasting panels are accepted for routine assessment in most guidelines. Fasting is still requested when triglycerides are very high or a specific calculation is needed.
My statin gives me muscle aches. Should I stop?
Not permanently. Stop for two to four weeks to see whether symptoms actually resolve, check thyroid and vitamin D, then rechallenge with a lower dose or a different statin. In blinded studies most such symptoms occurred equally on placebo.
Do I need regular liver tests on a statin?
A baseline before starting, and then only if symptoms suggest a problem. Routine periodic liver testing for everyone has been dropped because it found almost nothing and discouraged people from treatment.
What is lipoprotein(a) and should I have it measured?
A genetically determined particle raised in about one person in five, independently driving heart attack and stroke and unchanged by diet or statins. It is measured once in a lifetime, is not on a standard panel, and is worth requesting with any family history of early events.
When is high cholesterol inherited?
Familial hypercholesterolaemia affects about one person in 250, with LDL above 190 mg/dL, early heart attacks in the family, and sometimes lumps over the tendons. Each first-degree relative has a one in two chance of having it, so family testing matters.
What is added when a statin alone is not enough?
Ezetimibe 10 mg daily first, adding roughly a further 15 to 20 percent reduction with few side effects. Beyond that, bempedoic acid, PCSK9 inhibitor injections or inclisiran, reserved for very high risk.
Can I take antibiotics with my statin?
Clarithromycin and erythromycin block the enzyme that clears simvastatin and atorvastatin, raising the muscle risk, so the statin is usually paused for the course. The same applies to itraconazole and ketoconazole. Mention your statin whenever these are prescribed.
How much can diet lower my cholesterol?
Replacing saturated fat with unsaturated gives 5 to 10 percent, plant sterols at 2 g daily 8 to 10 percent, and soluble fibre about 5 percent. Combined, that approaches a low-dose statin, and it works alongside medication rather than instead of it.
📑 Sources and editorial
- ACC and AHA guideline on the management of blood cholesterol, and ESC and EAS dyslipidaemia guidelines, including risk categories, LDL goals and statin intensity definitions
- Cholesterol Treatment Trialists Collaboration meta-analyses of event reduction per unit LDL lowering
- Consensus statements on lipoprotein(a) measurement and interpretation, and on cascade screening in familial hypercholesterolaemia
- Blinded n-of-1 and randomised studies of statin-associated muscle symptoms, including placebo-controlled rechallenge designs, and guidance on the stepwise management of reported intolerance
- Guidance on the discontinuation of routine liver function and creatine kinase monitoring during statin therapy
- Prescribing information for simvastatin, atorvastatin, rosuvastatin, pravastatin, lovastatin, ezetimibe, fenofibrate and gemfibrozil, including the restriction on simvastatin 80 mg and CYP3A4 interactions
- Evidence for ezetimibe, bempedoic acid, PCSK9 inhibitors and inclisiran as add-on therapy
- Guidance on severe hypertriglyceridaemia and pancreatitis risk, and on fibrate selection alongside statins
- Consensus statements on non-fasting lipid measurement, and on statin-associated new-onset diabetes and its risk-benefit balance
- Meta-analyses of dietary saturated fat replacement, soluble fibre and plant sterols on LDL cholesterol
- Related reading: blood pressure, type 2 diabetes, type 3 hyperlipidaemia
- Related products: Zocor (Simvastatin), cholesterol category
- RXshop Editorial Team — reviewed by Robert Hayes, MD, FACC — Cardiologist & Cardiovascular Disease Specialist
Medical Disclaimer: The information in this article is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek guidance from a qualified healthcare provider with any questions you may have regarding a medical condition, and before starting, stopping or changing any medication.